EDTUTC-4 New YorkLog in Sign up

ENTX
Entera Bio Ltd.
stockNASDAQ

At CloseOct 2, 2026 3:59:53 PM EDT

2.85USD-1.384%(-0.04)100,701

Loading…

Loading…

494.32M

Healthcare

Biotechnology

HQ

Jerusalem, Jerusalem, Israel

19

Previous Close

$2.89

Beta

0.71

52-Week High

$4.20 2026-07-27

52-Week Low

$0.91 2026-03-30

SMA 50

$2.96

SMA 200

$1.80

Avg. Vol 10D

454,118

Avg. Vol 30D

396,285

Avg. Vol 90D

1.92M

Relative Vol

0.25

173.14M

40.37M

23.32%

1,281,818

Short Interest %

3.17%

3.57

On/Off Exchange

50%/50%

68.75%

Short Vol % (off-exch)

54.94%

9.5600%

550,000

31,725

6,392

31,725

Nov 13, 2026 (39d)

Oct 2, 2026

10:15 AM EDTShort Interest Alert: Most and least shorted sub-$2B healthcare stocks in Sep. 2026 ·

Seeking Alpha

Sep 25, 2026

04:06 AM EDTGuggenheim initiates Entera Bio stock with buy rating on oral peptide platform ·

Investing.com

Sep 18, 2026

08:30 AM EDTEntera Receives $9 Price Target and New ’Outperform’ Rating From Leerink Partners (NASDAQ: ENTX) ·

FinanceWire

ENTX Profile

entera bio ltd. is a biotechnology company located in israel.

ENTX Performance

Period	Price	Date	Change	Beta
1W	2.69	2026-09-28	+6.13%	-5.850
1M	3.00	2026-09-04	-4.83%	1.017
3M	1.71	2026-07-06	+66.96%	-0.120
6M	1.19	2026-04-06	+139.92%	0.219
1Y	1.90	2025-10-03	+50.26%	0.714
2Y	1.87	2024-10-04	+52.67%	—
5Y	4.72	2021-10-04	-39.51%	0.462

ENTX Stock Summary

Entera Bio Ltd. (NASDAQ:ENTX) stock price today is $2.86, and today's volume is 100,701. ENTX is down 1.211% today. The 30 day average volume is 396,285. ENTX market cap is $494.32M with 173.14M shares outstanding.